Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Yan Leyfman
Jul 12, 2024, 07:47 |
Blog
Potential breakthrough for patients with relapsed or refractory large B-cell lymphoma - Parker Institute for Cancer Immunotherapy
Yan Leyfman, Co-Founder and Executive Director at MedNews Week, shared a posted by Parker Institute…
Jun 24, 2024, 23:19 |
Blog
Make an impact in global medical education and research innovation with MedNews Week
MedNews Week made the following post on X: "MedNews Week is growing! Join our family and…
Jun 6, 2024, 00:32 |
Blog
Chandler Park: Mentor and Mentee Moment at ASCO24
Chandler Park shared a post on LinkedIn: . "Mentor and Mentee Moment at…
Oct 9, 2023, 18:51 |
Opinion
Urvi Shah: If you are a patient with myeloma or any plasma cell disorder please consider filling out this survey.
Urvi Shah, Attending Physician in Myeloma Service at Memorial Sloan Kettering Cancer Centre, shared on X/Twitter:…
May 24, 2023, 15:44 |
Positive
The results for the 2023 40 Under 40 in Cancer were announced!
Congratulations to all of the nominees and awardees! The members of the 2023 40 Under…
1
2
3
4
All:
35
Posts:
31 - 40
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Clinical Trials That Changed the Life of Cancer Patients: Insights from the CEO of EORTC, Dr. Denis Lacombe
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube